2931.90.22.00/Aromatic Silane Platinum Anti-Cancer Drug/Canada

Aromatic Silane Platinum Anti-Cancer Drug from Canada

Platinum-based chemotherapy agent with aromatic silane ligands, used in cancer treatment protocols. HTS 2931.90.22.00 classification applies to this aromatic organo-inorganic compound containing silicon and platinum linked to carbon.

Duty Rate — Canada → United States

6.5%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Submit molecular structure diagrams confirming Si-C and Pt coordination bonds

• Comply with cytotoxic drug import protocols including secondary containment packaging

• Verify against List 1 chemicals if platinum complex has precursor potential

Aromatic Silane Platinum Anti-Cancer Drug from Canada — Import Duty Rate | HTS 2931.90.22.00